Safety and Efficacy of Sufentanil Combined With Midazolam in Bronchoscopy Under Conscious Sedation: Retrospective Study
Overview
The aim of this study was to determine the safety and efficacy of sufentanil combined with midazolam in bronchoscopy under conscious sedation. A retrospective analysis was conducted on all patients undergoing bronchoscopy applying sufentanil and midazolam under conscious sedation in the First Affiliated Hospital of Guangzhou Medical University from September 2013 to July 2017.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: March 30, 2018
Interventions
- Drug: Sufentanil
- Patients were applied sufentanil and midazolam intravenously and topical anesthetized.
Arms, Groups and Cohorts
- Sufentanil and Midazolam
- Patients who had undergone bronchoscopy applying topical lidocaine, sufentanil and midazolam under conscious sedation in the First Affiliated Hospital of Guangzhou Medical University from September 2013 to July 2017 were included in this study.
Clinical Trial Outcome Measures
Primary Measures
- Oxygen desaturation
- Time Frame: during the procedure
- Percentage of patients whose oxygen saturation decreased to lower than 80% during procedure
Participating in This Clinical Trial
Inclusion Criteria
Patients who had undergone bronchoscopy applying topical lidocaine, sufentanil and midazolam under conscious sedation in the First Affiliated Hospital of Guangzhou Medical University from September 2013 to July 2017 Exclusion Criteria:
Patients who had undergone bronchoscopy not applying topical lidocaine, sufentanil and midazolam under conscious sedation
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Guangzhou Institute of Respiratory Disease
- Provider of Information About this Clinical Study
- Principal Investigator: ShiYue Li, Clinical Professor – Guangzhou Institute of Respiratory Disease
- Overall Official(s)
- Shiyue Li, Professor, Principal Investigator, The First Affiliated Hospital of Guangzhou Medical University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.